Technology and innovation drive each other
As a new generation of Acute Respiratory Support, the INSPIRA™ ART500 is designed to elevate and stabilize decreasing oxygen saturation levels in minutes without a mechanical ventilator.
Discover INSPIRATM ART500
A novel technology that could potentially bring hope to the 20 million patients each year who end up in intensive care units and are placed on mechanical ventilators.
To overcome the risks and medical complication associated with mechanical ventilator that require intubation and coma, the INSPIRA™ ART500 is designed to treat the patients while they are awake.
The INSPIRA™ ART500 targets to boost oxygen saturation levels to 95% or higher in minutes with small volumes of blood being monitored for the rapid detection of life-threatening medical conditions.
Challenging the foundations of Life Support to eliminate the need for mechanical ventilation treatment.
Market Size
Aiming to Revolutionize the $19 Billion
Mechanical Ventilation Market
±20 Millions / Year
on Mechanical Ventilation
Novel Patents
Inspira™ Patent Portfolio
VORTX™ | U.S Granted
Dual Lumen Cannula | U.S Granted
Initiation Module | U.S Granted
Cannula Fixation Device | U.S Filed
News & Events
October 22, 2025
Inspira and Bites Form Strategic Alliance to Embed AI as a Core Standard Across Inspira’s Global Ecosystem
October 21, 2025
